Passage BIO PASG
NASDAQ PASG
$4.12 -0.08 (-1.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Passage BIO (PASG) Selling, General & Administrative (2019 - 2026)

Updated

Passage BIO's Selling, General & Administrative came in at $6.87 million for Q2 2026, up 52.1% from $4.52 million a year earlier and up 43.6% from the prior quarter.

Analysis

Passage BIO (PASG) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Passage BIO reported Selling, General & Administrative of $20.93 million, down 7.3% year-over-year; for FY2025, it came in at $19.88 million, down 20.5% from FY2024.

  • Selling, General & Administrative has declined in each of the last four years, with a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $24.99 million in FY2024 (-39.9%), $41.58 million in FY2023 (-15.7%), $49.34 million in FY2022 (-17.8%) and $60.06 million in FY2021 (+99.4%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative since Q3 2024.
  • Year-over-year, Selling, General & Administrative increased in two of the last eight quarters, with an average decline of 9.8%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 92.2%), and the weakest in Q1 2024 (a decline of 65.8%).
  • Business Quant data shows PASG's Selling, General & Administrative at $4.79 million (Q1 2026), $4.92 million (Q4 2025) and $4.35 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Passage BIO 13.90 Mn 13.90 Mn - 6.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.87 Mn
Mar 31, 2026 4.79 Mn
Dec 31, 2025 4.92 Mn
Sep 30, 2025 4.35 Mn
Jun 30, 2025 4.52 Mn
Mar 31, 2025 6.09 Mn
Dec 31, 2024 4.71 Mn
Sep 30, 2024 7.25 Mn
Jun 30, 2024 6.51 Mn
Mar 31, 2024 6.52 Mn
Dec 31, 2023 6.29 Mn
Sep 30, 2023 8.18 Mn
Jun 30, 2023 8.06 Mn
Mar 31, 2023 19.05 Mn
Dec 31, 2022 10.59 Mn
Sep 30, 2022 10.66 Mn
Jun 30, 2022 12.99 Mn
Mar 31, 2022 15.10 Mn
Dec 31, 2021 17.19 Mn
Sep 30, 2021 14.98 Mn
API Access

Passage BIO Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PASG&period=max&api_key=YOUR_API_KEY